Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 100 of 609 entries
View as:

Clinical Evaluation of 0.1% Olopatadine Hydrochloride Ophthalmic Solution in Pediatric Patients

Phase: N/A Priority: Normal
NCT ID: NCT01109485 Org: User:
Start: 03/31/10 End: 07/31/11 Due: 07/31/12

Assessment of Intraocular Pressure (IOP) Control in Subjects With Open-Angle Glaucoma or Ocular Hypertension Treated With Travoprost 0.004% (TRAVATAN® Z) or Bimatoprost 0.01% (LUMIGAN®)

Phase: N/A Priority: Normal
NCT ID: NCT01464424 Org: User:
Start: 10/31/11 End: 06/30/12 Due: 06/30/13

Efficacy and Safety of RTH258 Versus Aflibercept - Study 1

Phase: N/A Priority: Normal
NCT ID: NCT02307682 Org: User:
Start: 12/08/14 End: 03/28/18 Due: 03/28/19

Short Term Comparative Study of Xalatan With Benzalkonium Chloride vs. Travatan Z Without Benzalkonium Chloride in Healthy Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT00468988 Org: User:
Start: 05/31/07 End: 07/31/07 Due: 07/31/08

ELAZOP Switching Study in Korea

Phase: N/A Priority: Normal
NCT ID: NCT01055366 Org: User:
Start: 03/31/10 End: 12/31/11 Due: 12/31/12

Evaluation of Contact Lenses and Conjunctival Staining in Normal Patients

Phase: N/A Priority: Normal
NCT ID: NCT00799422 Org: User:
Start: 11/30/08 End: 03/31/09 Due: 03/31/10

Efficacy and Safety of Brinzolamide/Brimonidine Fixed Combination BID Compared to Brinzolamide BID Plus Brimonidine BID in Subjects With Open-Angle Glaucoma (OAG) or Ocular Hypertension (OHT)

Phase: N/A Priority: Normal
NCT ID: NCT02339584 Org: User:
Start: 04/14/15 End: 11/01/16 Due: 11/01/17

Lens Wearing Experience and Biocompatibility of a Multi-Purpose Disinfecting Solution (MPDS)

Phase: N/A Priority: Normal
NCT ID: NCT01476722 Org: User:
Start: 06/30/11 End: 10/31/11 Due: 10/31/12

A Study of Glaucoma Therapy to Treat Open-Angle Glaucoma or Ocular Hypertension

Phase: N/A Priority: Normal
NCT ID: NCT00293761 Org: User:
Start: 01/31/06 End: 05/31/06 Due: 05/31/07

Evaluation of the Safety and Tolerability of Ocular Lubricants

Phase: N/A Priority: Normal
NCT ID: NCT06571656 Org: User:
Start: 04/02/25 End: 07/31/26 Due: 07/31/27

A Comparison of AIR OPTIX® COLORS Versus FRESHLOOK® COLORBLENDS

Phase: N/A Priority: Normal
NCT ID: NCT01635933 Org: User:
Start: 06/30/12 End: 09/30/12 Due: 09/30/13

Visual Function After Implantation of Bilateral AcrySof ReSTOR Aspheric +3

Phase: N/A Priority: Normal
NCT ID: NCT00719732 Org: User:
Start: 09/30/07 End: 05/31/09 Due: 05/31/10

Evaluation of Silicone Hydrogel Lens Wettability With Marketed Lens Care Solutions

Phase: N/A Priority: Normal
NCT ID: NCT01252134 Org: User:
Start: 11/30/10 End: 02/28/11 Due: 02/28/12

Next Generation Cataract Surgery Study

Phase: N/A Priority: Normal
NCT ID: NCT06071104 Org: User:
Start: 12/06/23 End: 06/28/24 Due: 06/28/25

Effect of Blue Light Filtration on Visual Performance

Phase: N/A Priority: Normal
NCT ID: NCT01938989 Org: User:
Start: 09/30/13 End: 01/31/14 Due: 01/31/15

A Comparison of Corneal Aberrations in Subjects With Contralateral AcrySof IQ Toric Intraocular Lens (IOL) and AcrySof IQ IOL With Limbal Relaxing Incision (LRI)

Phase: N/A Priority: Normal
NCT ID: NCT01045733 Org: User:
Start: 12/31/09 End: 05/31/11 Due: 05/31/12

Investigation of AcrySof® IQ PanOptix™ Presbyopia-Correcting Intraocular Lens (IOL) Model TFNT00

Phase: N/A Priority: Normal
NCT ID: NCT02529488 Org: User:
Start: 09/07/15 End: 06/26/17 Due: 06/26/18

A Study to Evaluate 0.003% AR-15512 Safety and Drop Attributes

Phase: N/A Priority: Normal
NCT ID: NCT06660290 Org: User:
Start: 01/15/25 End: 02/06/25 Due: 02/06/26

Acute Comfort and Blur Profile of a Lubricant Eye Drop Versus a Marketed Lubricant Eye Gel

Phase: N/A Priority: Normal
NCT ID: NCT01077011 Org: User:
Start: 01/31/10 End: - Due: -

Travacom Post Marketing Surveillance Study

Phase: N/A Priority: Normal
NCT ID: NCT01510132 Org: User:
Start: 01/31/12 End: 01/31/12 Due: 01/31/13

Travoprost 0.004%/Timolol 0.5% Versus Latanoprost 0.005%/Timolol in Chinese Patients With Open-Angle Glaucoma or Ocular Hypertension

Phase: N/A Priority: Normal
NCT ID: NCT00872651 Org: User:
Start: 01/31/10 End: 11/30/11 Due: 11/30/12

Clinical Study of a Fluid Accommodating Intraocular Lens (IOL) Design

Phase: N/A Priority: Normal
NCT ID: NCT05317728 Org: User:
Start: 03/31/23 End: 12/31/26 Due: 12/31/27

An Evaluation of the Nighttime Retention of Effect of an Investigational Lubricant Eye Drop (FID 115958D)

Phase: N/A Priority: Normal
NCT ID: NCT01165164 Org: User:
Start: 06/30/10 End: 07/31/10 Due: 07/31/11

Evaluation of Anti-Inflammatory Treatment in Dry Eye Patients

Phase: N/A Priority: Normal
NCT ID: NCT01276223 Org: User:
Start: 02/28/11 End: 01/31/12 Due: 01/31/13

Study of Brinzolamide and Timolol When Added to Travoprost in Primary Open-angle Glaucoma or Ocular Hypertension

Phase: N/A Priority: Normal
NCT ID: NCT00372827 Org: User:
Start: 02/29/04 End: 01/31/06 Due: 01/31/07